Results 121 to 130 of about 13,464,291 (195)

Administration of N,N-dimethyltryptamine (DMT) in psychedelic therapeutics and research and the study of endogenous DMT. [PDF]

Psychopharmacology (Berl), 2022
Barker SA.
europepmc   +1 more source

Reconstituting a two-step pathway for <i>N</i>,<i>N</i>-dimethyltryptamine (DMT) biosynthesis in bacteria. [PDF]

Metab Eng Commun
Junges LH, Pontes FLD, Mota FJT, Passaglia Bruschi G, Bonaldi MPF, de Souza EM, Müller-Santos M.   +6 more
europepmc   +1 more source

The clinical pharmacology and potential therapeutic applications of 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT). [PDF]

J Neurochem, 2022
Reckweg JT, Uthaug MV, Szabo A, Davis AK, Lancelotta R, Mason NL, Ramaekers JG.   +6 more
europepmc   +1 more source

A phase 1/2 trial to assess safety and efficacy of a vaporized 5-methoxy-N,N-dimethyltryptamine formulation (GH001) in patients with treatment-resistant depression. [PDF]

Front Psychiatry, 2023
Reckweg JT, van Leeuwen CJ, Henquet C, van Amelsvoort T, Theunissen EL, Mason NL, Paci R, Terwey TH, Ramaekers JG.   +8 more
europepmc   +1 more source

Neurochemical and Neurophysiological Effects of Intravenous Administration of <i>N,N</i>-Dimethyltryptamine in Rats. [PDF]

J Neurosci
Glynos NG, Huels ER, Groenhout T, Raghu A, Nelson A, Kim Y, Zeid AM, Liu T, Mashour GA, Kennedy RT, Pal D.   +10 more
europepmc   +1 more source

Synthesis and Biological Evaluation of 4‑Bromo-<i>N,N-</i>dimethyltryptamine (4-Br-DMT): A Synthetic Building Block for Future Analog Development. [PDF]

ACS Omega
Bray E, Glatfelter GC, Maitland AD, Gonzalez NR, Walther D, Yacoub J, Baumann MH, von Salm JL.   +7 more
europepmc   +1 more source

Rapid and sustained antidepressant effects of vaporized N,N-dimethyltryptamine: a phase 2a clinical trial in treatment-resistant depression. [PDF]

Neuropsychopharmacology
Falchi-Carvalho M, Palhano-Fontes F, Wießner I, Barros H, Bolcont R, Laborde S, Ruschi B Silva S, Montanini D, C Barbosa D, Teixeira E, Florence-Vilela R, Almeida R, K A de Macedo R, Arichelle F, J Pantrigo É, V Costa-Macedo J, da Cruz Nunes JA, de Araújo Costa Neto LA, Nunes Ferreira LF, Dantas Corrêa L, da Costa Bezerra RB, Arcoverde E, Galvão-Coelho N, B Araujo D.   +23 more
europepmc   +1 more source

Detection and Quantification of Psychoactive N,N‑Dimethyltryptamine in Ayahuasca Brews by Ambient Ionization High-Resolution Mass Spectrometry

ACS Omega, 2020
Megan I. Chambers, Meghan G. Appley, Cameron M. Longo, Rabi A. Musah   +3 more
doaj   +1 more source

Pharmacokinetics and pharmacodynamics of an innovative psychedelic N,N-dimethyltryptamine/harmine formulation in healthy participants: a randomized controlled trial. [PDF]

Int J Neuropsychopharmacol
Mueller MJ, Aicher HD, Dornbierer DA, Marten L, Suay D, Meling D, Elsner C, Wicki IA, Müller J, Poetzsch SN, Caflisch L, Hempe A, Steinhart CP, Puchkov M, Kost J, Landolt HP, Seifritz E, Quednow BB, Scheidegger M.   +18 more
europepmc   +1 more source

Acute dose-dependent effects and self-guided titration of continuous N,N-dimethyltryptamine infusions in a double-blind placebo-controlled study in healthy participants. [PDF]

Neuropsychopharmacology
Erne L, Vogt SB, Müller L, Nuraj A, Becker A, Klaiber A, Zuparic M, Varghese N, Eckert A, Rudin D, Luethi D, Liechti ME.   +11 more
europepmc   +1 more source